A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.

Multi-drug resistant falciparum malaria is an important health problem in the Peruvian Amazon region. We carried out a randomised open label clinical trial comparing mefloquine-artesunate, the current first line treatment in this region, with dihydroartemisinin-piperaquine.Between July 2003 and July...

Full description

Bibliographic Details
Main Authors: Tanilu Grande, Andrea Bernasconi, Annette Erhart, Dioni Gamboa, Martin Casapia, Christopher Delgado, Kathy Torres, Caterina Fanello, Alejandro Llanos-Cuentas, Umberto D'Alessandro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-10-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2040506?pdf=render